X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential Revenue Stream in 2014

Yuvraj_pawp by Yuvraj_pawp
5th June 2014
in Research & Development

As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and the Early Access to Medicines Scheme was introduced. Key implementation of this will be a factor into further commercialisation and developments.

Based on this information SMi Group is proud to announce it will be hosting the 3rd conference on Orphan Drugs and Rare Diseases and bringing together leading experts and companies such as Novabiotics, Pfizer, AstraZeneca, GMP Orphan SAS, Genethon and M&C Saatchi and many more to discuss the latest developments in the market.

 

Benefits of Attending:

  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Hear important insights from Ian Hudson, CEO, MHRA on the Early Access to Medicines Initiative and adaptive licensing
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Focus on enhancing development pathways, with the growth of the commercial pipeline for orphan drugs and rare diseases
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Assess tools for consideration to gain early market access and enhance patient recruitment
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Interactive round table discussion led by Dominic Nutt, Director of Communications, The Saatchi Cancer Initiative,M&C Saatchi on creating a culture of innovation in the field of orphan drugs and rare diseases

Key Speakers:

  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Dr Gunter Harms, Market Access & Public Affairs Directore, Shire

     

  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Bertram Haussle, Chaiman of the Board of Management, IGES Institut

     

  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Josie Godfrey, Associate Director-Highly Specialised Technologies, NICE

     

  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Chris Hart, Information Practice Leader, AstraZeneca

     

  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Anthony Hall, Co-Founder, Findacure Foundation

For more information please visit http://www.smi-online.co.uk/2014orphandrugs66.asp

If you would like to attend this conference as a delegate please contact John Collins on +44(0) 207 827 6128 or e-mailamccann@smi-online.co.uk 

If you are interested in sponsoring this event contact Alia Malick on +44(0)20 7827 6168 or email amalick@smi-online.co.uk

If you would like to become a media partner contact Sarah Watson on +44 (0)20 7827 6134 or email swatson@smi-online.co.uk

Previous Post

KIP THE HUMANS: DRUG DISCOVERY BY SIMULATING CELLS

Next Post

State-owned British research institute fund Clinical trial of Airsonett – an innovative Swedish asthma treatment

Related Posts

Tumors Can Get Destroyed By Bacteria-Aid To Immune System
News

Tumors Can Get Destroyed By Bacteria-Aid To Immune System

16th March 2023
News

Researchers Develop Revolutionary Treatment In Bone Cancer

10th March 2023
News

T Cells Are Fruitful In Thwarting-Off Chronic Infections

10th March 2023
News

Randomness Drives Tumour Cells Response To Chemotherapy

10th March 2023
Featured

Animal Testing Could See An End With An Artificial Model

28th February 2023
Featured

Germany Rolls First CAR-T Push For Muscle Inflammation Cure

27th February 2023
Next Post

State-owned British research institute fund Clinical trial of Airsonett – an innovative Swedish asthma treatment

Latest News

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In